SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-17-052424
Filing Date
2017-10-13
Accepted
2017-10-13 16:02:21
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tv476905_s3.htm S-3 406313
2 EXHIBIT 4.2 tv476905_ex4-2.htm EX-4.2 557042
3 EXHIBIT 4.3 tv476905_ex4-3.htm EX-4.3 597977
4 EXHIBIT 5.1 tv476905_ex5-1.htm EX-5.1 29874
5 EXHIBIT 5.2 tv476905_ex5-2.htm EX-5.2 6766
6 EXHIBIT 23.1 tv476905_ex23-1.htm EX-23.1 2412
7 GRAPHIC image_001.jpg GRAPHIC 15620
8 GRAPHIC image_003.jpg GRAPHIC 29896
9 GRAPHIC image_004.jpg GRAPHIC 13733
10 GRAPHIC image_005.jpg GRAPHIC 19916
  Complete submission text file 0001144204-17-052424.txt   1710996
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-220942 | Film No.: 171136658
SIC: 2834 Pharmaceutical Preparations